Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531 | ISIN: INE939A01011 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
826.8000 -18.45 (-2.18%)
NSE Jun 20, 2025 15:52 PM
Volume: 390.3K
 

logo
Strides Pharma Science Ltd.
edited 03 Mar 2020
826.80
-2.18%
Strides Consumer to focus on differentiated products to crack OTC business
Strides Consumer to focus on differentiated products to crack OTC business
Moneycontrol
Consumer healthcare sector in India is valued at $3 billion and expected to witness a twofold growth by 2024, said Subodh Marwah, CEO, Strides Consumer.
Promoters unpledged 2.27% of shares in last quarter. Total pledge stands at 51.98% of promoter holdings
Strides receives USFDA approval for tetracycline hydrochloride capsules
Business Line | 04 Mar 2020 1 more
More from Strides Pharma Science Ltd.
Recommended
Market closes higher, Hindustan Aeronautics bags an order worth Rs 500 crore from ISRO
Trendlyne Marketwatch | 20 Jun 2025, 03:59PM
Winners and losers of 2025 in global indices | Screener: Nifty outperformers (so far) this year
The Baseline | 19 Jun 2025, 11:24AM
Earnings Call Transcript - Q1FY21 for Strides Pharma Science
| 05 Aug 2020